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Abstract. Elkhateeb WA, Daba GM, Elnahas MO, Thomas PW, Emam M. 2020. Metabolic profile and skin-related bioactivities of 
Cerioporus squamosus hydromethanolic extract. Biodiversitas 21: 4732-4740.  Being a functional food capable of showing nutritional 
as well as medicinal properties have great attention. Mushrooms have been proven as leading targets in this field. For this purpose, the 
edible mushroom Cerioporus squamosus was investigated in this study to evaluate the in vitro skin-related bioactivities of its 
hydromethanolic extract in terms of enhancing wound healing, and human skin cancer suppression capabilities. Treatment of fibroblast 
cells (BJ-1) with the hydromethanolic extract of this mushroom at 50 µg/mL enhanced cell migration rates by 71.7% after 24 h of 
exposure to the extract. Moreover, the same extract exhibited a promising impact on human skin cancer using an epidermoid carcinoma 
cell line (A431). The gradual increase in C. squamosus hydromethanolic extract concentration caused gradual decrease in the A431 cell 
viability and proliferation. Maximum effect on reducing the cell viability was obtained at a concentration of 100 µg/mL, where cell 
viability was 3.7%, and recorded IC50 was 52.6 µg/mL. The metabolic profile of the extract was analyzed by GC-MS, which was 
performed on its silylated metabolites. Nineteen compounds were detected including sugar alcohols, amino acids, fatty and organic 
acids. Promising results of this mushroom extract encourage conducting further steps towards using this mushroom as a functional food 
showing promising bioactivities. 
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INTRODUCTION  
Without ignoring its functional roles in sensation 
and touch, the biofunctions of the largest human organ, the 
skin, include also protecting the body from losing excess 
water, and from external factors as sun, microbes. 
Moreover, the skin contribute principally in the process of 
body temperature regulation (James et al. 2011).   
Skin injuries and wounds have a range of different 
etiologies and they should be healed as fast as possible in 
order to regain the lost tissues, allow the skin to continue 
its functions, and to continue tissue homeostasis. Wound 
healing and new tissue formation mechanisms are multistep 
complex processes that start with inflammation, then 
angiogenesis, followed by granulation tissue formation, re-
epithelialization, and extracellular matrix reconstruction 
(Bolla et al. 2019). After a skin injury, immune cells 
quickly multiply, migrate to the injured location, and 
initiate wound healing mechanisms. Fibroblasts are the 
major cells existing in skin tissue, they rupture fibrin clots, 
generate extracellular matrix constituents as well as 
collagen structures that are needed for tissue homeostasis 
(Bainbridge 2013). Historically, a wide range of plant 
species was used for their wound healing properties and, 
even today, wound healing pharmaceuticals which are 
based mainly on plants represent more than 70% of 
available products (Kumarasamyraja et al. 2012). 
Similarly, natural extracts originating from medicinal 
mushrooms have formed the basis of many studies, with a 
growing interest in identifying extracts potent as wound 
healing agents. Ganoderma lucidum (reishi mushroom), 
Handkea utriformis (synonym of Calvatia utriformis), 
Hericium erinaceus, Morchella esculenta, Sparassis crispa, 
and Agaricus blazei are among the fungi species that have 
previously shown promising wound healing abilities 
(Gupta et al. 2014; Elkhateeb et al. 2019c). 
Malignant growths or tumors, resulting from 
uncontrolled cell division occur throughout the body and 
those that are specific to skin appear to be increasing, 
globally. Generally, there are two main types of skin cancer 
(melanoma and non-melanoma). Non-melanoma skin 
cancer is ranked as the 5th most commonly occurring 
cancer, accounting for an estimated 1.04 million deaths in 
2018, while melanoma skin cancer is the 19th most 
commonly occurring cancer, and the incidences of non-
melanoma and melanoma skin cancers have been 
increasing in recent decades (WHO Fact sheet, 2018). 
Generally, several mushroom species have shown 
ELKHATEEB et al. – Skin related bioactivities of Cerioporus squamosus extract 
 
4733 
promising in vitro and in vivo abilities against cancer 
(Ivanova et al. 2014; Blagodatski et al. 2018; Ray et al. 
2020). Very few mushrooms have been testified to have 
anti-skin cancer activities such as Ganoderma lucidum, and 
Coriolus versicolor (Chinembiri et al. 2014). G. lucidum 
extract has been demonstrated to have an anti-melanoma 
effect in vitro, and tumor-reducing activities in vivo. G. 
lucidum induces apoptosis (cancer cell death) and inhibits 
proliferation of skin cancer cells (Harhaji Trajković et al. 
2009), while C. versicolor extract caused a reduction in 
growth of melanoma cells and tumor volume, through 
inhibiting cell proliferation and inducing apoptotic and 
necrotic cell death (Harhaji et al. 2008).  
Screening for natural potent compounds that are 
capable of improving wound healing process and showing 
at the same time anti-skin cancer activity is attracting 
researcher’s attention in modern pharmaceutical and 
biomedical sciences. Edible mushrooms are put under the 
scientific spotlight as they are already edible and can act as 
a source for bioactive compounds that may supplement 
and/or replace currently used drugs.  
Cerioporus squamosus (Huds.) Quél. is a 
basidiomycetous edible mushroom, C. squamosus is 
generally known as dryad’s saddle or pheasant’s back 
mushroom and is usually existing in the northern temperate 
zones.  
C. squamosus extracts have been evaluated for their 
potential biological activities and they have previously 
been reported to have antioxidant, wound healing, and 
antimicrobial activities (Zhao 2013; Fernandes et al. 2016; 
Mocan et al. 2018; Elkhateeb et al. 2019c). However, the 
anti-skin cancer activity of this promising mushroom has 
not been investigated before. In this study, we strive to 
explore the potential in vitro anti-skin cancer properties 
along with the wound healing potency of C. squamosus 
methanolic extract. 
MATERIALS AND METHODS 
Sample collection, identification, and extraction  
For this study, whole fruiting bodies of Cerioporus 
squamosus (Huds.) Quél. (syn. Polyporus squamosus 
(Huds.) Fr.) were collected from the Isle of Bute, in 
Scotland (UK). Fruiting bodies were found growing in 
clusters and were readily identified as the target species, 
displaying a cap with the following properties: a fan-shape, 
broadly convex but becoming flat and shallowly depressed 
in older specimens. The caps were pale tan to creamy 
yellowish, with large and flattened, brown to blackish 
scales. Pores ran down the stem, whitish to creamy (white 
spore print), and displayed no bruising. Flesh was thick and 
moderately tough with a strongly mealy aroma (Figure 
1). All samples were collected from the same tree host, 
which was a previously felled trunk of Aesculus 
hippocastanum (Sapindaceae). Which had become 
colonized with C. squamosus fruit bodies. Cerioporus 
squamosus identification was carried out using the 
morphological features according to Phillips (2013). 
Samples were collected on the 1st of June 2018 and 
were immediately sliced and dried in a commercial heated 
dehydrator at approximately 75°C (GP-102-1, 250W, 
LASER 2000, Westfalia Werkzeug company GmbH & Co 
KG, Germany). After dehydration, samples were extracted 
as described previously (Elkhateeb et al. 2019d; Daba et al. 
2020). Briefly, C. squamosus fruiting body pieces were 
placed in an Erlenmeyer flask containing 80% methanol at 
room temperature and kept overnight before filtering. The 
resulting filtered extract was concentrated at 37°C using a 
rotary evaporator. The obtained extract was stored at 4°C in 






   
 
Figure 1. Fruiting bodies of Cerioporus squamosus collected from the Isle of Bute, in Scotland (UK). Photographs were taken by Dr. 
Paul W Thomas 
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Metabolic profile of C. squamosus hydromethanolic 
extract by GC-MS analysis   
GC-MS analysis of silylated metabolites  
Metabolite analysis was carried out as follows. Briefly, 
100 mg of finely powdered C. squamosus was extracted 
with 5 mL 100% methanol with sonication for 30 min with 
frequent shaking, followed by centrifugation at 12,000×g 
for 10 min to remove debris. 100 µL of the methanolic 
extract was aliquoted in screw-cap vials and left to 
evaporate until complete dryness. For derivatization, 150 
µL of N-methyl-N-(trimethylsilyl)-tri fluoroacetamide 
(MSTFA) that was previously diluted 1:1% with an 
hydrous pyridine added to the dried methanolic extract and 
incubated at 60°C for 45 min prior to analysis using GC-
MS (Farag et al. 2018). 
GC-MS analysis of C. squamosus extract 
The GC-MS analysis of the extract was conducted as 
described by Elkhateeb et al. (2019d) using a TRACE GC 
Ultra Gas Chromatographs (THERMO Scientific Corp., 
USA), coupled with a thermo mass spectrometer detector 
(ISQ Single Quadrupole Mass Spectrometer). Helium was 
used during the analyses as carrier gas at a flow rate of 1.0 
mL/min and a split ratio of 1:10. The program of 
temperature started with 60°C for 1 min; followed by rising 
temprature at 4.0 °C/min to 240 °C and held for 1 min. The 
injector and detector were held at 210°C. Diluted samples 
(1:10 hexane, v/v) of 1 μl of the mixtures were always 
injected. After that, mass spectra were measured by 
electron ionization (EI) at 70 eV, under a spectral range of 
m/z 40-450. 
In vitro wound healing activity of C. squamosus 
hydromethanolic extract 
The wound healing activity of C. squamosus 
hydromethanolic extract and the migration rates of BJ-1 
cells were evaluated in the Bioassay-cell Culture 
Laboratory, National Research Center, Dokki, Egypt. using 
the scratch assay method.  BJ-1 cell line is human skin 
fibroblast that is derived from normal foreskin and was 
obtained from American Type Culture Collection, ATCC® 
CRL-2522™, Manassas, VI, USA)The cell density of 2 × 
105 cells were seeded into each well of a 24-well plate and 
incubated with complete medium at 37°C and 5% CO2. 
After 24 h of incubation, the monolayer confluent cells 
were scrapped horizontally with a sterile P200 pipette tip. 
The debris was removed by washing with PBS. The cells 
were treated with C. squamosus methanolic extract at 
concentration 50, 100, 200 µg/mL. The cells without 
treatment were used as negative control. The induced 
scratch that represented the wound was photographed at 0 h 
using phase-contrast microscopy at ×40 magnification, 
before incubation with the samples. After 24 h of 
incubation, the second set of images was photographed. To 
determine the migration rate, the images were analyzed 
using “image J” software, and percentage of the closed area 
was measured and compared with the value obtained at 0 h. 
An increase in the percentage of the closed area was taken 
as an indication for the cell migration. Experiments were 
performed in the triplicate and the data were recorded and 
analyzed statistically using SPSS 11. 
 
Wound closure (%) = (Measurement at 0 h −Measurement after 24 h) ×100 
Measurement at 0 h 
In vitro anti-skin cancer activity of C. squamosus 
hydromethanolic extract  
The in vitro anti-skin cancer study was performed in the 
Bioassay-cell culture laboratory, National Research Centre, 
Dokki, Egypt. Cell viability assay was assessed by the 
mitochondrial-dependent reduction of yellow MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) to 
reduced purple formazan (Mosmann 1983). 
This experiment was conducted under sterile conditions 
via a Laminar flow cabinet biosafety class II level (Baker, 
SG403INT, Sanford, ME, USA). In this experiment, A431 
cell line was used. A431 is human squamous cell 
carcinoma, A431 (ACC 91, DSMZ German collection of 
microorganisms and cell cultures, Braunschweig, 
Germany). First, skin cancer cells (A431) were suspended 
in DMEM-F12 medium, together with 1% antibiotic-
antimycotic mixture (10,000 U/mL potassium penicillin, 
10,000 µg/mL streptomycin sulfate and 25 µg/mL 
amphotericin B) and 1% L-glutamine. The experiment was 
conducted at 37 ºC under 5% CO2. 
A431 skin cancer cells were batch cultured for 10 days, 
then at a concentration of 104 cells/well they were seeded 
in a fresh complete growth medium in 96-well microtiter 
plastic plates under 5% CO2 at 37 ºC for 24 hr using a 
water-jacketed carbon dioxide incubator (Sheldon, 
TC2323, Cornelius, OR, USA). Media was aspirated and 
then fresh medium (without serum) was added. The cells 
were incubated either alone (negative control) or with 
different concentrations of C. squamosus hydromethanolic 
extract with final concentrations of (12.5, 25, 50, and 100 
µg/mL). The medium was aspirated after 48 hr of 
incubation and 40 µL MTT salt (2.5 μg/mL) were added to 
each well. Finally, the plates were incubated for four more 
hours under the same conditions.  
Two hundred μl of 10% Sodium dodecyl sulfate (SDS) 
in deionized water was added after the end of incubation to 
each well then the plate was incubated overnight at 37ºC. 
Adrinamycin® (Pharmacia India Pvt Ltd. Gurgaon, 
Haryana 122001, India) was used as a positive control 
(Thabrew et al. 1997), and medium free of tested extract 
was used as negative control. Color intensity was measured 
at 595 nm using a microplate multi-well reader (Bio-Rad 
Laboratories Inc., model 3350, Hercules, California, USA) 
and a reference wavelength of 620 nm. A statistical 
significance was tested between samples and negative 
control using independent t-test by SPSS 11 program. The 
change in viability percentage was calculated as following:  
 
((As/Ac) -1) × 100 
 
Where;  
(As) is sample absorbance, and (Ac) is negative control 
absorbance. IC50 was determined by SPSS 11 program. 
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RESULTS AND DISCUSSION 
Metabolic profile identified from C. squamosus 
hydromethanolic extract 
GC-MS analysis performed on the silylated metabolites 
originating from the hydromethanolic extract of C. 
squamosus fruiting bodies revealed detection of 19 
compounds (Figure 2, Table 1). The total peak areas of the 
detected compounds were 70.76% and SI ≥ 750, the 
probabilities of the structures of the detected compounds 
are listed in Table 1. The peak area% representing the 
sugar alcohol, xylitol, was the major peak (28.59%), 
followed by that of palmitic acid (17.43%), then glycerol 
(10.94%). The extract also contained amino acids such as 
alanine, L-valine, L-isoleucine, L-threonine. Moreover, 
many organic and fatty acids were detected such as D-
lactic acid, oxalic acid, myristic acid, stearic acid, 
pentadecanoic acid, and dodecanoic acid (lauric acid). The 
sugar alcohols - sorbitol, and erythritol were also identified 
in small peak areas of 3.01, and 0.22%, respectively. 
In vitro wound healing activity of C. squamosus 
hydromethanolic extract towards human skin fibroblast 
((BJ-1) cells 
The effect of C. squamosus hydromethanolic extract on 
the migration of fibroblast cells (BJ-1) was investigated 
because cell migration plays a key role in wound repair and 
healing. As shown in Figures 3, and 4 after 24 h of 
exposure to C. squamosus hydromethanolic extract, cells 
migrated towards the provisional gap induced. Migration 
analysis values showed that 50 µg/mL of the C. squamosus 
extract was the concentration causing the highest increase 
in cell migration (71.7%). Further increase in extract 
concentration was accompanied with decrease in migration 
rate until reached 3.24% after 24 h of exposure to a 





Figure 2. GC-MS chromatogram of the silylated metabolites 




Figure 3. The percentage of migration rate for BJ-1 cells after 24 h of 
treatment with Cerioporus squamosus  hydromethanolic extract. 
 
Table 1. Identified compounds of silylated Cerioporus squamosus  extract using GC-MS 
 
No. RT Area % Compound name Molecular weight Molecular formula SI 
1 4.89 0.24 Alanine 89 C3H7NO2 860 
2 5.40 0.30 Ethanedioic acid (Oxalic acid) 90 C2H2O4 752 
3 6.94 0.34 L-Valine 117 C5H11NO2 868 
4 8.00 10.94 Glycerol 92 C3H8O3 927 
5 8.42 0.28 L-Isoleucine 131 C6H13NO2 880 
6 10.10 0.24 L-Threonine 119 C4H9NO3 824 
7 12.06 0.22 Erythritol 122 C4H10O4 920 
8 12.18 0.69 meso-Erythritol 122 C4H10O4 931 
9 13.77 0.13 2-Deoxyribitol 136 C5H12O 834 
10 15.05 2.08 Dodecanoic acid 200 C12H24O2 911 
11 15.58 28.59 Xylitol 152 C5H12O5 927 
12 16.88 0.33 D-Psicofuranose 180 C6H12O 850 
13 18.08 2.07 Tetradecanoic acid (Myristic acid) 228 C14H28O2 898 
14 18.59 3.01 sorbitol (glucitol) 182 C6H14O6 901 
15 18.68 0.20 2,2'-oxybis(ethan-1-ol) 106 C4H10O3 753 
16 19.52 0.74 Pentadecanoic acid 242 C15H30O2 740 
17 20.85 17.43 Hexadecanoic acid (Palmitic Acid) 256 C16H32O2 866 
18 23.10 2.34 2-hydroxy Propanoic acid (D-lactic acid)
 90 C3H6O3 779 
19 23.44 0.59 Octadecanoic acid (Stearic Acid) 284 C18H36O2 759 
Note: Total identified % is 70.76 and SI ≥ 750 
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Figure 4. Wound healing ability of Cerioporus squamosus  hydromethanolic extraction to BJ-1 cells. Images were acquired at (A) 50 
µg/mL 0 h, and (B) 50 µg/mL after 24 h of exposure to extract. (C) 100 µg/mL 0 h, and (D) 100 µg/mL after 24 h of exposure to 
extract.  (E) 200 µg/mL 0 h and (F) 200 µg/mL after 24 h of exposure to extract.  Images were analyzed using “image J” software, and 




Effect of C. squamosus hydromethanolic extract on the 
viability of A431 human squamous cell carcinoma skin 
cancer cell line 
The viability or the proliferation of the skin cancer cell 
line (A431) was tested by the MTT assay (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). 
This is a colorimetric assay that measures cell metabolic 
activity. Here, NAD(P)H-dependent cellular oxidoreductase 
enzymes, which is an indicator of the cell viability, was 
measured. The function of this enzyme is to reduce the 
tetrazolium dye of the MTT which in turn forms an 
insoluble purple colored formazan that dissolved in 
acidified alcohol and finally measured at 595 nm.  
Using the MTT assay, different concentrations of the C. 
squamosus hydromethanolic extract (12, 25, 50, 100 
µg/mL) were examined to evaluate their capabilities to 
inhibit A431 skin cancer cell proliferation. Results shown 
in Figure 5 revealed the promising effect of the mushroom 
extract on reducing A431 cell proliferation. This appeared 
as a gradual decrease in cell viability with the gradual 
increase of C. squamosus hydromethanolic extract 
concentration (Figure 6). The maximum cell viability 
reducing ability was obtained using a concentration of 100 
µg/mL recording a cell viability % of 3.7, and the IC50 was 
found to be 52.6 µg/mL. 
 
 
50 µg/mL; 0 h 50 µg/mL; 24 h 
100 µg/mL; 0 h 100 µg/mL; 24 h 
200 µg/mL; 0 h 200 µg/mL; 24 h 
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Figure 5.A. A431 skin cancer cell line before treatment with C. squamosus hydromethanolic extract. B. A431 skin cancer cell line after 
treatment with 100 µg/mL of Cerioporus squamosus  hydromethanolic extract for 48 h 
 
 
Figure 6. Cerioporus squamosus  hydromethanolic extract 
reduced the proliferation of A431 skin cancer cells. A431 cells 
were cultured in the presence of 0, 12.5, 25, 50, and 100 µg/mL of 
the extract for 48 h and followed by measuring the cell viability 
via MTT assay. Error bars represent mean ± SD where *p ≤ 0.05; 
**p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001 indicates a significant 





Mushrooms are generous sources of metabolites with 
promising bioactivities. Moreover, being edible encourages 
further investigation to authorize their application in 
medicines and pharmaceuticals. Studies on many 
mushroom species such as Ganoderma lucidum, Cordyceps 
militaris, Hericium erinaceus, Metacordyceps neogunnii 
(Synonym of  Keithomyces neogunnii), and Dictyophora 
indusiata revealed their potent in vitro biological 
capabilities as anticoagulant, antiviral, hypocholestero-
lemic, anti-colon cancer, and antioxidant agents (Elkhateeb 
et al. 2019b; Elkhateeb et al. 2019c; El-Hagrassi et al. 
2020; Daba et al. 2020). Furthermore, some mushrooms 
have promising wound healing activities (Buko et al. 2019; 
Elkhateeb et al. 2019c; Kosanić et al. 2020). Cerioporus 
squamosus is an edible, basidiomycetous mushroom that is 
rich in macronutrients, organic acids, fatty acids and other 
important compounds (Elkhateeb et al. 2019a). 
Additionally, C. squamosus has been used as medicine for 
its diuretic, antimicrobial, cytotoxic, immuno-enhancing, 
anti-inflammatory, hepatoprotective, nephroprotective, 
antioxidant activities, and stimulate hair growth (Doskocil 
et al. 2016; Fernandes et al. 2016; Elkhateeb et al. 2019a). 
Understanding the effects of C. squamosus extract on 
mammalian cells is required, to provide the basis for the 
development of a novel and safe product useful for 
treatment of various diseases. In this study, the wound 
healing, and anti-human skin cancer activities of the 
hydromethanolic extract of C. squamosus were 
investigated. Moreover, chemical analysis was performed 
on the hydromethanolic C. squamosus methanolic extract 
in order to detect its bioactive metabolites.  
The in vitro evaluation of the anticancer activity of C. 
squamosus hydromethanolic extract against epidermoid 
carcinoma A431 cell line revealed its promising anticancer 
effect, which showed its optimum action after treatment 
with extract at concentration of 100 µg/mL where the cell 
viability was 3.7%.  
It is important to mention that the current work 
represents the first study investigating the effect of C. 
squamosus hydromethanolic extract on human skin cancer 
cell lines. As shown from the GC-Ms analysis of the 
sialylated metabolites originated from C. squamosus 
extract, 19 compounds were detected and listed in table 1. 
More than quarter of the area percentage of the total 
detected metabolites (28.59%) was occupied by xylitol - 
sugar alcohol. Xylitol has various biological activities and 
is used most commonly in oral hygiene products due to its 
anti-inflammatory and anticaries characteristics (Nayak et 
al. 2014). Many in vitro studies on cancer cell lines have 
elucidated the dose-dependent inhibitory role of xylitol on 
cell proliferation, which is suggested to be achieved 
through autophagy (Park et al. 2015).  
Moreover, a recent study had suggested that partial 
substitution of glucose with sugar alcohols especially 
xylitol could deeply suppress proliferation of oral cancer 
but not non-transformed cells (Trachootham et al. 
2017). One of the highly detected metabolites in C. 
squamosus hydromethanolic extract is palmitic acid 
(representing 17.43 area %). Long-chain fatty acids, such 
as palmitic acid, were testified in many studies to have 
cytotoxic and antiproliferative activities against cancer 
cells by inhibiting DNA topoisomerase I and inducing 
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apoptosis in human leukemic cells (Harada et al. 2002; 
Ravi and Krishnan 2017). Glycerol, which is also detected 
in C. squamosus extract (10.94%), has inhibitory effects on 
growth and invasion of some human cancer cell lines 
(Sakurai et al. 2011). Interestingly, the majority of 
remaining compounds detected in the hydromethanolic 
extract of C. squamosus have also been reported to have 
anti-cancer properties. Sorbitol has anticancer activities 
against several tumor models (Lu et al. 2014) through 
inducing apoptosis in an efficient and rapid way when 
provided at high concentrations as a part of hyperosmotic 
stress mechanisms (Marfè et al. 2008). Sorbitol was 
reported in many studies for its ability to activate the p38 
MAPK signal transduction pathway and induce the 
apoptosis of tumor cells (Marfè et al. 2008). Additionally, 
the medium-chain length fatty acid, dodecanoic acid, which 
is known also as lauric acid has well reported anticancer 
activity (Sandhya et al. 2016). In previous in vitro studies, 
lauric acid has induced apoptosis in colon cancer cells due 
to oxidative stress (Fauser et al. 2013). Also, lauric acid has 
induced cell death in colon cancer cells settled by the 
epidermal growth factor receptor down-regulation (Sheela 
et al. 2019).  
Generally, the overall pattern obtained after many in 
vitro studies on different cell lines revealed that even the 
lauric acid-containing derivatives were the most effective 
anticancer agent (Chhikara et al. 2011). On the other hand, 
several studies have suggested that selective amino acid 
deprivation of serine and glycine or phenylalanine and 
tyrosine can inhibit tumor growth in animal models 
(Maddocks et al. 2017). Alanine and glutamic acid-induced 
apoptosis of gastric cancer cells (Gu et al. 2015), β-alanine 
exhibited a co-therapeutic activity in the treatment of breast 
tumors and reduced cancerous metabolism besides 
reducing extracellular acidification which leads to 
suppressed aggressiveness. Also, β-alanine increased the 
efficacy of Dox on MCF-7 cells at low concentrations 
(Vaughan et al. 2014). Oxalic acid, which was also one of 
the metabolites detected in the extract, has been reported 
for its therapeutic effect for controlling, and treating, 
neoplasia, tumors, including brain tumors, and for 
preventing the new growth of different or abnormal tissues 
(Hart et al. 2000). However, it should be noted that some 
studies have reported the ability of oxalate to induce breast 
cancer when injected into mice mammary fat pad 
(Castellaro et al. 2015). 
It is worth noting that cancer patients (including skin 
cancer patients ) are subjected to various physiological 
changes including the process of the disease itself, 
treatment course, social situation as well as poor nutritional 
status and in combination, these factors may contribute to 
delay of wound healing processes (Payne et al. 2008). 
Wound healing is an important biological mechanism 
that occurs in the human body and includes the well-
regulated steps; hemostasis, inflammation, proliferation, 
and finally remodelling (Guo and DiPietro 2010). Several 
factors can interfere with one or more of these process 
steps resulting in impaired or delayed wound healing, such 
as diabetes mellitus, hypertension, venous stasis disease, 
cancer disease as well as some treatments, age-related 
health issues, and nutritional status (Menke et al. 2007). 
A 2018 analysis of Medicare beneficiaries in the USA 
reported about 8.2 million (14.5%) suffered from wounds 
including both infected and non-infected (By 
microorganisms).  Moreover, the Medicare cost estimated 
for curing these wounds ranged from $28.1 billion to $96.8 
billion. It is expected that the annual cost for medical 
products for wound care alone, could reach $15–22 billion 
by 2024 (Sen 2019). Hence, its crucial to find new low-cost 
wound treatments primarily originating from natural 
sources with low toxicity and minimal side effects. 
Nowadays, the interest of many scientists has been 
directed to phytomedicine due to the demonstrated ability 
of many plants to aid in the healing of wounds. However, 
little is known about the wound healing properties of 
mushrooms to heal wounds (Elkhateeb et al. 2019c). So, 
we were interested to evaluate the ability of C. squamosus 
mushrooms to treat wounds via the scratch assay in order to 
develop a natural product that promotes wound healing in 
cancer patients and specifically “skin cancer patients”. The 
results showed that promising anti-skin cancer effect, 
especially helpful to the cancer patients suffering from 
delayed and impaired wound healing.  
The effect of C. squamosus hydromethanolic extract on 
the migration of BJ-1 normal human fibroblast cells was 
tested, where different concentrations of C. squamosus 
hydromethanolic extract (ranging from 50-200 µg/mL) 
were added to BJ1 monolayer confluent cells and it was 
found that the extract exhibits an obvious effect on wound 
healing where the migration rate at the concentration of 50 
µg/mL was 71.7%. However, any further increase in the 
extract concentration (beyond 50 µg/mL) was accompanied 
by gradual decrease in migration rate until it reached the 
level of 3.24% at the concentration of 200 µg/mL after 24 
hours of incubation. As the lowest tested concentration 
displayed the highest migration rate, it remains possible 
that the optimal concentration level may be below 50 
µg/mL and further investigation will be needed to identify 
this optimum.  
The results obtained from GC-MS may help explain 
these results. The obtained profile of the analyzed 
hydromethanolic extract contains 19 compounds that are 
classified into different groups. They are mainly amino 
acids, sugar alcohols, fatty acids, and carbohydrates (see 
table 1). Lately, some studies have focused on examining 
the roles of various immune nutrients such as amino acids, 
fatty acids, and minerals on wound healing (Silva et al. 
2018).  
Our results showed the presence of four amino acids: 
alanine, L-valine, L-isoleucine, and L-threonine. Many of 
amino acids play a vital role in building and repairing 
human body tissues and are therefore pivotal in wound 
healing. The human body can create some of these amino 
acids but not all of them and the deficit must be supplied 
from foods (Council 1989). 
Arginine (detected in C. squamosus extract) is well 
known for its great role in wound healing. Arginine 
accelerates insulin secretion, promotes protein 
regeneration, and helps transport amino acids into the cells. 
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It is worth mentioning that 32% of arginine is nitrogen and 
it is the only producer of nitric oxide. Nitric oxide is an 
important role in wound healing as it increases blood flow 
and oxygen supply to the wound and also increasing 
collagen formation (Williams et al. 2002) and limiting the 
inflammation process. Being an edible mushroom, C. 
squamosus could be very helpful in wound healing. 
Moreover, some studies showed that L-valine, L-
isoleucine, and L-threonine also promote the wound 
healing process and these are also amino acids that cannot 
be produced by the human body. Branched amino acids 
such as L-valine and L-isoleucine are crucial in building 
muscles and hence wound healing, and these two amino 
acids are different than others in that they are metabolized 
in the muscle and not in the liver (Stengler 2010). Amino 
acids are found in different forms, however, the optimum 
form utilized by the human body is the L-form (Stengler 
2010), which is the principal form present in C. squamosus 
extract and further supports the conclusion that the present 
extract is a very promising aid to wound healing.  
Several fatty acids were also detected in the C. 
squamosus extract. Fatty acids are generally classified on 
the basis of the presence of double bonds into saturated (no 
double bonds) and unsaturated (with double bonds) fatty 
acids (Calder 2011; Silva et al. 2018). Some fatty acids 
may have a role in healing processes. In a previous study, 
treatment of a Zebrafish (Danio rerio) model with linoleic 
acid containing lucuma nut oil, accelerated cell 
regeneration. This may be attributed to increasing 
angiogenesis, resuming the oxygen and nutrient supply 
which in turn promotes wound healing (Silva et al. 2018). 
Taken together, our results showed that C. squamosus 
could be a promising treatment with dual action for skin 
cancer patients who suffer from impaired wound healing, 
thus limiting the viability of skin cancer cells as well as 
triggering normal cells to heal. 
Having a multi-functional natural source of bioactive 
compounds is a property of high demand. Especially so, if 
this source is already an edible one with a history of use by 
people for its nutritional and medical capabilities. C. 
squamosus hydromethanolic extract has shown promising 
in vitro skin-related bioactivities with potent anti-skin 
cancer and wound healing abilities. Results presented in 
this study encourage further investigation in order to 
evaluate the in vivo potentials of this extract. As far as we 
know, this is the first study that describes a significant 
impact on human skin cancer activity by C. squamosus 
hydromethanolic extract. Moreover, this work represents a 
significant step toward evaluating the real therapeutic 
potential of the edible mushroom C. squamosus. 
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